منابع مشابه
The Prevalence of Drug-Drug Interaction and Inappropriate Drug Prescription Among the Elderly in Kashan
Background: Drug-drug Interaction (DDI) among the elderly is one of the major healthcare challenges worldwide. The present study assessed the rates of DDI and inappropriate drug prescription among the elderly in Kashan City, Iran. Methods: This descriptive-analytical study was designed, conducted, and reported according to the guideline of Strengthening the Reporting of Observational Studies ...
متن کاملDrug Utilization and Inappropriate Prescribing in Centenarians
OBJECTIVES To use primary care electronic health records (EHRs) to evaluate prescriptions and inappropriate prescribing in men and women at age 100. DESIGN Population-based cohort study. SETTING Primary care database in the United Kingdom, 1990 to 2013. PARTICIPANTS Individuals reaching the age of 100 between 1990 and 2013 (N = 11,084; n = 8,982 women, n = 2,102 men). MEASUREMENTS Main ...
متن کاملInappropriate prescribing and adverse drug events in older people
Inappropriate prescribing (IP) in older patients is highly prevalent and is associated with an increased risk of adverse drug events (ADEs), morbidity, mortality and healthcare utilisation. Consequently, IP is a major safety concern and with changing population demographics, it is likely to become even more prevalent in the future. IP can be detected using explicit or implicit prescribing indic...
متن کاملPotentially inappropriate drug prescribing and associated factors in nursing homes.
IMPORTANCE Polymedication is frequent in nursing home (NH) residents. This increases the risk of potentially inappropriate drug prescribing (PIDP), which can lead to adverse drug events, such as falls and hospitalization. OBJECTIVE To identify PIDP in NH residents and to investigate subject-related and NH structural and organizational factors associated with PIDP. DESIGN Cross-sectional stu...
متن کاملPhenomenon of Inappropriate Drug Manufacturing in China - Past and Present.
It is an unspoken fact that Chinese manufacturers have been copying drugs inappropriately, despite these drugs having worldwide patent protection1, such as Abilify® (aripiprazole) for schizophrenia, depression and bipolar disorder, ALIMTA® (pemetrexed) for non-small cell lung cancer, Spiriva® (tiotropium bromide) for chronic obstructive pulmonary disorder (COPD), and Detrol® (tolterodine) for o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Anaesthesia
سال: 2002
ISSN: 0003-2409
DOI: 10.1046/j.1365-2044.2002.270932.x